Lipodystrophy: Still an underdiagnosed complication of subcutaneous insulin administration

Clin Case Rep. 2022 Mar 4;10(3):e05551. doi: 10.1002/ccr3.5551. eCollection 2022 Mar.

Abstract

Lipodystrophy is a common but often underdiagnosed complication of subcutaneous insulin injections. We present an illustrative case, aiming to remind physicians to consider lipodystrophy when evaluating a patient under insulin therapy with otherwise unexplained metabolic decompensation. A complete physical examination and patient education are crucial in this setting.

Keywords: diabetes mellitus; diagnosis; insulin; lipodystrophy.